Update of primary Helicobacter pylori resistance to antimicrobials in Brussels, Belgium.
Diagn Microbiol Infect Dis
; 95(4): 114875, 2019 Dec.
Article
em En
| MEDLINE
| ID: mdl-31474463
ABSTRACT
This study aimed to follow the trend of primary antimicrobial resistance in Helicobacter pylori isolates obtained from several centers in Brussels. We observed increasing rates of primary resistance to macrolides (10.5% to 18%) to nitro-imidazoles (28% to 40%) and to fluoroquinolones (12.4% to 22.8%), respectively, from 2008/2009 to 2016.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Helicobacter pylori
/
Infecções por Helicobacter
/
Farmacorresistência Bacteriana
/
Antibacterianos
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article